Research Opportunity For Healthy Volunteers age 10-25
Accelovance has an opportunity for healthy volunteers between the ages of 10-25 to take part in a vaccine trial for Meningococcal disease (MnB):
• Meningococcal disease type B (MnB) is caused by a certain type of bacteria that can make you very sick.
• No vaccine to prevent MnB is currently available
Young people ages 10-25 may be eligible to take part in a clinical trial to test an investigational vaccine for MnB.
Participants may receive:
Reimbursement up to $300 for time & travel.
Created by Accelovance
1600 W. Eau Galle Blvd, #102
Melbourne, FL 32935